Ischemic Heart Disease Drugs Market 2018 Growth, COVID Impact, Trends Analysis Report 2023

 Ischemic Heart Disease Market is expected to grow at a moderate rate during the forecast period 2018-2023. Ischemic heart disease, also known as CHD (coronary heart diseases) and CAD (coronary artery disease) is caused by defect and damage in the heart. Silent ischemia is one of the most prevailing ischemic diseases across the globe, caused by heart attack without prior warning. Moreover, the people having previous heart attacks or have diabetes are more prone to silent ischemia. Unhealthy dietary habits such as excessive consumption of alcohol & tobacco and lack of exercise increase the risk of ischemic heart diseases around the globe.

 

Request a Free Sample of our Ischemic Heart Disease Drugs Market:  https://www.omrglobal.com/request-sample/ischemic-heart-disease-market

Various pivotal factors that are augmenting the ischemic heart disease market includes growing incidence and prevalence rate of hypertension, high cholesterol, diabetes, and obesity across the globe. Government funding for diagnosis, treatment and research and their initiative programs to increase the awareness toward disease is another major factor augmenting the growth of the market. However, the high costs of treatment coupled with the regular uncertainty seen in reimbursement policies can hamper the growth of the market. Opportunities that are expected to augment the market includes increasing awareness among people towards the heart diseases and improving healthcare system and healthcare spending in emerging economies.

A full Report of Ischemic Heart Disease Drugs Market is Available at:  https://www.omrglobal.com/industry-reports/ischemic-heart-disease-market

A number of pipeline products by the major market player and various devices & drugs are expected to get Food and Drug Administration (FDA) approval which is also contributing in the growth of the market. For instance, in March 2017, FDA approved COBRA PzF NCS (NanoCoated coronary stent) system in order to improve coronary luminal diameter in certain patients with ischemic heart disease. In May 2018, the US FDA approved the use of replacement heart valve in paediatric patients during the treatment of heart diseases.

Global ischemic heart disease market is further analyzed on the basis of the geographical regions which are contributing significantly in the market. On the basis of geography, the market is divided into North America, Europe, Asia-Pacific, and Rest of the World. North America and Europe are expected to have a major market for ischemic heart disease during the forecast period. As per the Centers for Disease Control and Prevention (CDC), around 800,000 mortalities are reported due to ischemic disease every year in the US. As per the European Heart Network, around 3.9 million mortalities are reported due to CVDs (cardiovascular diseases) every year in Europe, wherein, nearly 1.8 million cases are reported in European Union. Asia-Pacific is projected to exhibit the fastest growth in the global ischemic heart diseases market during the forecast period. This is mainly owing to the rising prevalence of heart diseases and strokes and increasing awareness towards CAD.

Ischemic Heart Disease Drugs MARKETSEGMENTATION

ByDiseaseType

  • Angina
    MyocardialInfarction
    IschemicStroke
    ByDiagnosisMethod

  • Electrocardiogram (ECG)
    Echocardiogram
    ChestX-Ray
    CardiacCatheterization
    CoronaryAngiogram


ByTreatment


  • Medication
    NSAID
    Statins
    Blocker
    CalciumChannelBlocker
    ACEInhibitors
    Others (OrganicNitrates)
    Surgery
    CoronaryStent
    Angioplasty


COMPETITIVELANDSCAPE


  • KeyStrategyAnalysis
    KeyCompanyAnalysis


REGIONALANALYSIS


  • NorthAmerica
    UnitedStates
    Canada
    Europe
    UK
    Germany
    Italy
    Spain
    France
    RoE
    Asia-Pacific
    India
    China
    Japan
    RestofAsia-Pacific
    RestoftheWorld (RoW)


COMPANYPROFILES


  • AbbottLaboratories
    AmgenInc.
    AstraZenecaPLC
    BayerAG
    BostonScientificCorp.
    CardinalHealth, Inc.
    DaiichiSankyoCo. Ltd.
    EdwardsLifesciencesCorp.
    GeneralElectricCo.
    Genentech, Inc.
    KoninklijkePhilipsN.V.
    LepuMedicalTechnology (Beijing) Co., Ltd.
    Medtronic, PLC
    MerckKGaALtd.
    SanofiSA
    SiemensHealthcarePvt. Ltd.
    StrykerCorp.
    TERUMOCORP.
    W. L. Gore & Associates, Inc.

For More Customized Data, Request for Report Customization @  https://www.omrglobal.com/report-customization/ischemic-heart-disease-market

About Orion Market Research 

Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services.

For More Information, Visit Orion Market Research

Media Contact:

Company Name: Orion Market Research

Contact Person: Mr. Anurag Tiwari

Email: info@omrglobal.com

Contact no:  +91 7803040404

Comments

Popular posts from this blog

European Data Backup and Recovery Market Size, Share, Analysis, Industry Report and Forecast 2019-2025

Insect Repellent Market Is Likely to Experience a Tremendous Growth by 2031

Asia-Pacific Urban Air Mobility Market Growth, Size, Share, Industry Report and Forecast 2019-2025